Posted by Michael Wonder on 16 May 2017
Senate Inquiry releases prostheses list pricing report
16 May 2017 - The Senate Inquiry report on ‘Price regulation associated with the Prostheses List Framework', which was presented to the Senate last week, agreed with recommendations that the pricing reform process ought not disadvantage Australian manufacturers.
In tabling the report, the Chair of the Community Affairs References Committee, Senator Rachel Siewert, echoed AusBiotech’s recommendations to the Inquiry.
Senator Siewert said (Hansard, 11 May): “We have to be careful. It is very simple to say, 'We've got to reduce the prices of prostheses,' but we also need to make sure that, for example—as the evidence was presented to us—Australian manufacturers are not disadvantaged by that.”
